|
(L1) 6501.2245-Alprostadil, 500 Mcg/Ml, Injectable Solution, Ampoule/Vial-Ampule, 1Ml, Route Of Administration: Intravenous, Units. Size: Unit, (L2) 6501.1221-Anlodipine, Besylate, 5 Mg, Tablet, Blister, Route Of Administration: Oral, (L3) 6501.1226-Azithromycin Dihydrate, 500 Mg, Coated Tablet, (L4) 6501.288-Betamethasone, Acetate + Betamethasone, Disodium Phosphate, 3 + 3 Mg/Ml, Injectable Suspension, Ampoule, 1 Ml, Route Of Administration: Intramuscular / Intra-Articular / Intralesional / Soft Tissue, (L5) 6501.4245-Betamethasone, Dipropionate + Betamethasone, 5 + 2 Mg/Ml, 04/13/2026 - 15:00:03, (L6) 6501.2681-Cabergoline, 0, (L7) 6501.3142-Voriconazole, 200 Mg, (L8) 6501.512-Clonidine, Hydrochloride, 1 Mg, (L9) 6501.549-Dexchlorpheniramine, Maleate, 4 Mg/Ml, Oral Solution, Bottle, 100 To 120 Ml, Dosing Cup/Syringe, (L10) 6502.1180-Periciazine, 10 Mg/Ml (1%), Drops Solution, Dripper Bottle, 20 Ml, Ordinance 344/98: C1, (L11) 6501.22725-Dropropizine, 3 Mg/Ml, Syrup, 120 Ml, (L12) 6501.2557-Dibasic Sodium Phosphate + Monobasic Sodium Phosphate, 06 + 0, 16 G/Ml, Enema, Applicator Bottle, 100 To 133 Ml, Via Administration: Rectal, (L13) 6501.1381-Zinc Oxide + Retinol (Vitamin A) + Cholecalciferol (Vitamin D), 150 Mg + 5,000 Iu + 900 Iu/G, Dermatological Ointment, Tube, 45 G, Route Of Administration: Topical, (L14) 6501.48885-Saccharomyces Boulardii, 100Mg, Capsule, (L15) 6502.1138-Haloperidol
|
